Satici Sakine, Iyngkaran Pupalan, Andrew Sharon, Patil Arun, Bidargaddi Niranjan, Battersby Malcolm, De Courten Maximilian
Victoria University, PO Box 14428 Melbourne Victoria 8001, Melbourne, Australia.
University of Notre Dame, Werribee Mercy Sub School, School of Medicine Sydney, 300 Princes Hwy, Werribee VIC 3030, Australia.
Rev Cardiovasc Med. 2021 Mar 30;22(1):105-114. doi: 10.31083/j.rcm.2021.01.272.
Heart Failure (HF), a common chronic disease, requires multidisciplinary care to optimise outcomes. The COVID-19 pandemic, its impact on people's movement and access to health services, introduced severe challenges to chronic disease management. The era that will evolve after this pandemic is likely to provide uncertainty and service model disruptions. HF treatment is based on guidelines derived from randomised clinical trial evidence. Translational shortfalls from trials into practice have been overcome with post-trial service improvement studies like OPTIMIZE-HF where a team using a process of care can translate evidence to the general population. However, gaps remain for vulnerable populations e.g. those with more severe HF, with multiple comorbid conditions, and certain demographic groups and/or residents in remote locations. Health technology has come with great promise, to fill some of these gaps. The COVID-19 pandemic provides an opportunity to observe, from Australian healthcare lens, HF management outside the traditional model of care. This narrative review describes relatively recent events with health technology as a solution to improve on service gaps.
心力衰竭（HF）是一种常见的慢性疾病，需要多学科护理以优化治疗结果。2019年冠状病毒病（COVID-19）大流行及其对人们行动和获得医疗服务的影响，给慢性病管理带来了严峻挑战。这场大流行之后即将到来的时代可能会带来不确定性和服务模式的中断。HF治疗基于来自随机临床试验证据的指南。通过像优化心力衰竭治疗（OPTIMIZE-HF）这样的试验后服务改进研究，已经克服了从试验到实践的转化不足，在该研究中，一个使用护理流程的团队可以将证据转化应用于普通人群。然而，弱势群体，如那些患有更严重HF、有多种合并症的人群以及某些特定人口群体和/或偏远地区居民，仍然存在差距。卫生技术带来了很大的希望，以填补其中一些差距。COVID-19大流行提供了一个机会，从澳大利亚医疗保健的视角观察传统护理模式之外的HF管理情况。这篇叙述性综述描述了将卫生技术作为改善服务差距的解决方案的近期相关事件。
